Insulin Delivery Hardware: Pumps and Pens

Overview

Journal Diabetes Technol Ther

Specialties Endocrinology
Pharmacology

Date 2022 Apr 27

PMID 35475688

Authors

Rayhan Lal

Lalantha Leelarathna

Affiliations

Soon will be listed here.

References

Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U . Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA. 2017; 318(14):1358-1366. PMC: 5818842. DOI: 10.1001/jama.2017.13994. View

Rizza R, Vigersky R, Rodbard H, Ladenson P, Young Jr W, Surks M . A model to determine workforce needs for endocrinologists in the United States until 2020. Diabetes Care. 2003; 26(5):1545-52. DOI: 10.2337/diacare.26.5.1545. View

Aronson R, Reznik Y, Conget I, Castaneda J, Runzis S, Lee S . Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab. 2016; 18(5):500-7. PMC: 5071718. DOI: 10.1111/dom.12642. View

Jeyam A, Colhoun H, McGurnaghan S, Blackbourn L, McDonald T, Palmer C . Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care. 2020; 44(2):390-398. DOI: 10.2337/dc20-0567. View

Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese B . Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017; 7(7):e016587. PMC: 5642652. DOI: 10.1136/bmjopen-2017-016587. View

Kelly T, Sanborn G, Haug P, Edwards C . Effect of insulin infusion pump use on diabetic retinopathy. Arch Ophthalmol. 1984; 102(8):1156-9. DOI: 10.1001/archopht.1984.01040030934017. View

Lal R, Maahs D, Dosiou C, Aye T, Basina M . THE GUIDED TRANSFER OF CARE IMPROVES ADULT CLINIC SHOW RATE. Endocr Pract. 2020; 26(5):508-513. PMC: 7220827. DOI: 10.4158/EP-2019-0470. View

Bain S, Klufas M, Ho A, Matthews D . Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review. Diabetes Obes Metab. 2018; 21(3):454-466. PMC: 6587545. DOI: 10.1111/dom.13538. View

Girardot S, Jacquemier P, Mousin F, Rendekeu C, Hardy S, Riveline J . All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates. Diabetes Technol Ther. 2020; 22(6):476-483. DOI: 10.1089/dia.2019.0486. View

10.

Freckmann G, Kamecke U, Waldenmaier D, Haug C, Ziegler R . Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems. Diabetes Technol Ther. 2019; 21(4):201-208. PMC: 6477586. DOI: 10.1089/dia.2018.0376. View

11.

Laubner K, Singler E, Straetener J, Siegmund T, Path G, Seufert J . Comparative Dose Accuracy of Durable and Patch Insulin Pumps Under Laboratory Conditions. Diabetes Technol Ther. 2019; 21(7):371-378. DOI: 10.1089/dia.2019.0089. View

12.

Bell K, Smart C, Steil G, Brand-Miller J, King B, Wolpert H . Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015; 38(6):1008-15. DOI: 10.2337/dc15-0100. View

13.

Pickup J, Reznik Y, Sutton A . Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials. Diabetes Care. 2017; 40(5):715-722. DOI: 10.2337/dc16-2201. View

14.

Cook C, Beer K, Seifert K, Boyle M, Mackey P, Castro J . Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years' experience with 253 cases. J Diabetes Sci Technol. 2012; 6(5):995-1002. PMC: 3570832. DOI: 10.1177/193229681200600502. View

15.

Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J . Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014; 384(9950):1265-72. DOI: 10.1016/S0140-6736(14)61037-0. View

16.

Fang M, Wang D, Coresh J, Selvin E . Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021; 384(23):2219-2228. PMC: 8385648. DOI: 10.1056/NEJMsa2032271. View

17.

Pickup J . Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012; 366(17):1616-24. DOI: 10.1056/NEJMct1113948. View

18.

Lal R, Cuttriss N, Haller M, Yabut K, Anez-Zabala C, Hood K . Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care. Clin Diabetes. 2020; 38(2):159-165. PMC: 7164993. DOI: 10.2337/cd19-0060. View

19.

Paterson M, Bell K, OConnell S, Smart C, Shafat A, King B . The Role of Dietary Protein and Fat in Glycaemic Control in Type 1 Diabetes: Implications for Intensive Diabetes Management. Curr Diab Rep. 2015; 15(9):61. PMC: 4512569. DOI: 10.1007/s11892-015-0630-5. View

20.

Stewart A . The United States endocrinology workforce: a supply-demand mismatch. J Clin Endocrinol Metab. 2008; 93(4):1164-6. DOI: 10.1210/jc.2007-1920. View